drugset / Trial / NCT02060916
Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
NaSingle-groupSingle-blindTreatment
Summary
This study is to evaluate the effect that PAZ320 has on post-prandial glucose excursions measured via continuous glucose monitoring and its adverse effect profile in humans.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PAZ320 | Unknown | — | — |